Literature DB >> 3524708

Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation.

R G Knowlton, V A Brown, J C Braman, D Barker, J W Schumm, C Murray, T Takvorian, J Ritz, H Donis-Keller.   

Abstract

The use of DNA markers known as restriction fragment length polymorphisms is a sensitive and informative method of distinguishing patient and allogeneic donor cells after bone marrow transplantation. To apply the test, it is necessary in each case to find DNA probes that display patient-specific and donor-specific bands in Southern transfer hybridization. We have isolated a set of 12 cloned DNAs from highly polymorphic loci by which siblings can usually be distinguished. With just four of these probes, we can expect to distinguish the genotypes of the recipient and a sibling donor in more than 99% of cases (except between identical twins). The availability of many highly polymorphic probes also allows selection of an optimal probe for each case, one that can detect both the patient and donor-specific bands in a single hybridization with maximum resolution and sensitivity. We have applied these probes to the analysis of cells from peripheral blood and bone marrow after transplantation and demonstrated their usefulness in confirming engraftment of donor cells or graft rejection, and in detecting mixed lympho-hematopoietic chimerism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524708

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  BamHI polymorphism of locus D2S44 in a West German population as revealed by VNTR probe YNH24.

Authors:  L Henke; S Cleef; M Zakrzewska; J Henke
Journal:  Int J Legal Med       Date:  1990-12       Impact factor: 2.686

Review 2.  Molecular genetic testing for adult-onset disorders: the evolving laboratory, physician, patient interface.

Authors:  R T Acton
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 3.  The map of chromosome 20.

Authors:  N E Simpson
Journal:  J Med Genet       Date:  1988-12       Impact factor: 6.318

4.  Genetic linkage analysis of hereditary arthro-ophthalmopathy (Stickler syndrome) and the type II procollagen gene.

Authors:  R G Knowlton; E J Weaver; A F Struyk; W H Knobloch; R A King; K Norris; A Shamban; J Uitto; S A Jimenez; D J Prockop
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

5.  Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis.

Authors:  D H Oliver; R E Thompson; C A Griffin; J R Eshleman
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

6.  Amplification of human minisatellites by the polymerase chain reaction: towards DNA fingerprinting of single cells.

Authors:  A J Jeffreys; V Wilson; R Neumann; J Keyte
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

7.  Identification of more than 500 RFLPs by screening random genomic clones.

Authors:  J W Schumm; R G Knowlton; J C Braman; D F Barker; D Botstein; G Akots; V A Brown; T C Gravius; C Helms; K Hsiao
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

8.  Allele-specific DNA identity patterns.

Authors:  J S Wainscoat; S Pilkington; T E Peto; J I Bell; D R Higgs
Journal:  Hum Genet       Date:  1987-04       Impact factor: 4.132

9.  Autoimmune polyendocrine failure--type 1 (insulin-dependent) diabetes mellitus and hypothyroidism--after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia.

Authors:  B Vialettes; D Maraninchi; M P San Marco; F Birg; A M Stoppa; C Mattei-Zevaco; C Thivolet; L Hermitte; P Vague; P Mercier
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

10.  Cytogenetic studies using Q-band polymorphisms in patients with AML receiving marrow from like-sex donors.

Authors:  M T Khokhar; S D Lawler; R L Powles; J L Millar
Journal:  Hum Genet       Date:  1987-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.